| Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results A Heczey, X Xu, AN Courtney, G Tian, GA Barragan, L Guo, CM Amador, ... Nature Medicine 29 (6), 1379-1388, 2023 | 46 | 2023 |
| Transcriptomic and cellular analyses of CRISPR/Cas9-mediated edition of FASN show inhibition of aggressive characteristics in breast cancer cells F Gonzalez-Salinas, R Rojo, C Martinez-Amador, J Herrera-Gamboa, ... Biochemical and Biophysical Research Communications 529 (2), 321-327, 2020 | 19 | 2020 |
| Characterizing genes associated with cancer using the CRISPR/Cas9 system: A systematic review of genes and methodological approaches F Gonzalez-Salinas, C Martinez-Amador, V Trevino Gene 833, 146595, 2022 | 8 | 2022 |
| HARNESSING CRISPR/CAS9 MUTAGENESIS SCREENING FOR RATIONAL DESIGN OF NEXT-GENERATION CAR-NKT THERAPY AGAINST NEUROBLASTOMA G Tian, X Rios, C Zhang, J Drabek, C Amador, L Metelitsa PEDIATRIC BLOOD & CANCER 69, S229-S229, 2022 | 1 | 2022 |
| Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results A Heczey, X Xu, AN Courtney, G Tian, GA Barragan, L Guo, CM Amador, ... Nature medicine, 2024 | | 2024 |
| GD2-CAR NKTS CAN INDUCE ANTITUMOR RESPONSES IN CHILDREN WITH NEUROBLASTOMA (NB) AND BTG1 REPRESSION CAN FURTHER BOOST THEIR THERAPEUTIC POTENTIAL IN NB MODELS AA Heczey, X Xu, AN Courtney, G Tian, GA Barragan, L Guo, CM Amador, ... PEDIATRIC BLOOD & CANCER 71, S8-S8, 2024 | | 2024 |
| Metastatic colorectal micropapillary carcinoma presenting as lymphangitic lung carcinomatosis CA Lopez-Garcia, I Garcia-Hernandez, DM López-Sotomayor, ... Clinical Journal of Gastroenterology 14, 193-197, 2021 | | 2021 |
Fernando González-SalinasPhD Student, Tecnologico de MonterreyVerified email at itesm.mx
